Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Treatment considerations in actinic keratosis
Gary Goldenberg
Journal of the European Academy of Dermatology and Venereology (2017) Vol. 31, Iss. S2, pp. 12-16
Open Access | Times Cited: 37

Showing 1-25 of 37 citing articles:

Phase 3 Trials of Tirbanibulin Ointment for Actinic Keratosis
Andrew Blauvelt, Steven Kempers, Edward Lain, et al.
New England Journal of Medicine (2021) Vol. 384, Iss. 6, pp. 512-520
Open Access | Times Cited: 128
Treatment of actinic keratosis: a systematic review
Brandon Worley, Vishnu Harikumar, Kelly A. Reynolds, et al.
Archives of Dermatological Research (2022)
Closed Access | Times Cited: 30
Tirbanibulin for Actinic Keratosis: Insights into the Mechanism of Action
Todd Schlesinger, Eggert Stockfleth, Ayman Grada, et al.
Clinical Cosmetic and Investigational Dermatology (2022) Vol. Volume 15, pp. 2495-2506
Open Access | Times Cited: 27
Tirbanibulin 1% Ointment Significantly Reduces the Actinic Keratosis Area and Severity Index in Patients with Actinic Keratosis: Results from a Real-World Study
Michael C. Kirchberger, M. Gfesser, Michael Erdmann, et al.
Journal of Clinical Medicine (2023) Vol. 12, Iss. 14, pp. 4837-4837
Open Access | Times Cited: 11
Pharmacokinetics, Safety, and Tolerability of a Single 5‐Day Treatment of Tirbanibulin Ointment 1% in 100 cm2: A Phase 1 Maximal‐Use Trial in Patients with Actinic Keratosis
Janet DuBois, Terry M. Jones, Mark S. Lee, et al.
Clinical Pharmacology in Drug Development (2024) Vol. 13, Iss. 2, pp. 208-218
Open Access | Times Cited: 4
Clinical and experimental aspects of tirbanibulin treatments
Annabel Shen, Rebecca A. Simonette, Peter L. Rady, et al.
Archives of Dermatological Research (2025) Vol. 317, Iss. 1
Closed Access
Safety and tolerability of tirbanibulin ointment 1% treatment on 100 cm2 of the face or scalp in patients with actinic keratosis: A phase 3 study
Neal Bhatia, Edward Lain, Abel Jarell, et al.
JAAD International (2024) Vol. 17, pp. 6-14
Open Access | Times Cited: 3
High‐frequency (20 MHz) high‐intensity focused ultrasound: New Treatment of actinic keratosis, basal cell carcinoma, and Kaposi sarcoma. An open‐label exploratory study
Jørgen Serup, Torsten Bove, Tomasz Zawada, et al.
Skin Research and Technology (2020) Vol. 26, Iss. 6, pp. 824-831
Open Access | Times Cited: 22
Tirbanibulina: revisión de su mecanismo de acción novedoso y de cómo encaja en el tratamiento de la queratosis actínica
Yolanda Gilaberte, María Teresa Fernández‐Figueras
Actas Dermo-Sifiliográficas (2021) Vol. 113, Iss. 1, pp. 58-66
Open Access | Times Cited: 20
Long-term improvement on photoaging after ALA photodynamic therapy for actinic keratosis: A retrospective study
Linglin Zhang, Zijun Zhao, Peiru Wang, et al.
Photodiagnosis and Photodynamic Therapy (2021) Vol. 33, pp. 102181-102181
Closed Access | Times Cited: 18
Systematic Literature Review and Network Meta-analysis of the Efficacy and Acceptability of Interventions in Actinic Keratoses
Khaled Ezzedine, C. Painchault, M. Brignone
Acta Dermato Venereologica (2020) Vol. 101, Iss. 1, pp. adv00358-adv00358
Open Access | Times Cited: 20
Combination therapy with imiquimod and 5-fluorouracil cream for the treatment of actinic keratoses, a prospective open-label nonrandomized uncontrolled pilot trial
R. Maxwell Regester, Amy C. Cannella, Julianna Hirz, et al.
Journal of the American Academy of Dermatology (2024) Vol. 90, Iss. 6, pp. 1247-1249
Closed Access | Times Cited: 2
Expert Recommendations on Facilitating Personalized Approaches to Long-term Management of Actinic Keratosis: The Personalizing Actinic Keratosis Treatment (PAKT) Project
C.A. Morton, Samira Baharlou, Nicole Basset‐Séguin, et al.
Acta Dermato Venereologica (2023) Vol. 103, pp. adv6229-adv6229
Open Access | Times Cited: 6
Safety of topical interventions for the treatment of actinic keratosis
Elias A. T. Koch, Anja Wessely, Theresa Steeb, et al.
Expert Opinion on Drug Safety (2021) Vol. 20, Iss. 7, pp. 801-814
Closed Access | Times Cited: 11
The Role of Field Cancerization in Selecting Therapies for Actinic Keratosis: An Expert Consensus Panel
Danny Zakria, Milaan Shah, Joshua Burshtein, et al.
SKIN The Journal of Cutaneous Medicine (2024) Vol. 8, Iss. 3, pp. 1478-1487
Open Access | Times Cited: 1
Photographic scale for the characterization of actinic keratosis through reflectance confocal microscopy: a quantitative approach to cellular transformation
Lucas Offenbecker Guerra, Ana Carolina Leão Santos, Janaina Rosa Cortinoz, et al.
Frontiers in Medicine (2024) Vol. 11
Open Access | Times Cited: 1
[Translated article] Tirbanibulin: review of its novel mechanism of action and how it fits into the treatment of actinic keratosis
Yolanda Gilaberte, María Teresa Fernández‐Figueras
Actas Dermo-Sifiliográficas (2022) Vol. 113, Iss. 1, pp. T58-T66
Open Access | Times Cited: 7
Method of Assessing Skin Cancerization and KeratosesTM (MASCK™): development and photographic validation in multiple anatomical sites of a novel assessment tool intended for clinical evaluation of patients with extensive skin field cancerization
Christopher M. Baker, Amelia C. James, Madeleine Supranowicz, et al.
Clinical and Experimental Dermatology (2022) Vol. 47, Iss. 6, pp. 1144-1153
Open Access | Times Cited: 7
Topical Pharmacological Treatment of Actinic Keratoses: Focus on Tirbanibulin 1% Ointment
Mario Valenti, Matteo Bianco, Alessandra Narcisi, et al.
Dermatology Practical & Conceptual (2024) Vol. 14, Iss. S1, pp. e2024145S-e2024145S
Open Access | Times Cited: 1
DIN SPEC 91315: A First Attempt to Implement Mandatory Test Protocols for the Characterization of Plasma Medical Devices
Veronika Hahn, Ronny Brandenburg, Thomas von Woedtke
Springer eBooks (2018), pp. 511-516
Closed Access | Times Cited: 10
The Importance of Medication Adherence in the Treatment of Actinic Keratosis: An Expert Consensus Panel
Danny Zakria, April W. Armstrong, Brian Berman, et al.
SKIN The Journal of Cutaneous Medicine (2023) Vol. 7, Iss. 3, pp. 752-763
Open Access | Times Cited: 2
A Single-Arm, Open-Label, Phase IV Study to Evaluate the Efficacy of a Topical Formulation for Hyperkeratotic Actinic Keratosis Lesions
Maria Pia De Padova, Barbara Marzani, Daniela Pinto, et al.
Dermatology and Therapy (2018) Vol. 8, Iss. 3, pp. 455-462
Open Access | Times Cited: 5
Swiss (German) Version of the Actinic Keratosis Quality of Life questionnaire
Larissa S. Meier, Maria Schubert, Yasemin Azize Goksu, et al.
Dermatology (2018) Vol. 234, Iss. 1-2, pp. 51-59
Closed Access | Times Cited: 4
Self-expressed patient preferences for the treatment of actinic keratosis: results from a non-interventional study based on a real-life setting in Spain
Ana Julia García‐Malinis, Tamara Gracia‐Cazaña, Yolanda Gilaberte
European Journal of Dermatology (2018) Vol. 28, Iss. 1, pp. 113-115
Closed Access | Times Cited: 3
Management of Xeroderma Pigmentosum
Deborah Tamura, Ryusuke Ono, John J. DiGiovanna, et al.
Springer eBooks (2018), pp. 203-221
Closed Access | Times Cited: 3
Page 1 - Next Page

Scroll to top